A Narrative Review of Prevalence of Her2 Positive Invasive and Non Invasive Breast Cancer
Review Journal of Neurological & Medical Sciences Review · 2025
DOI: 10.62019/kw5f4656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Review Journal of Neurological & Medical Sciences Review, 2025. Verfasst von Sidra Jabeen und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Breast cancer is a prevalent malignancy in women globally, with the HER2-positive subtype exhibiting aggressive characteristics. This review examines the prevalence of HER2-positive breast cancer, focusing on both invasive and non-invasive forms. HER2, a transmembrane tyrosine kinase receptor, is overexpressed in a significant subset of breast cancers, influencing tumor behavior and prognosis. The review also explores the impact of HER2 status on disease progression and the effectiveness of current therapeutic strategies. Understanding the prevalence of HER2-positive breast cancer is crucial for tailoring effective treatments and improving patient outcomes.
Zitieren
APA
Jabeen, S., Afshan, R., Baig, M., Ahtsham, M., Ahmed, S., Ali, R., Kashif, A., Zhaira*, D., Gulzar, N., & Raja, Z. (2025). A Narrative Review of Prevalence of Her2 Positive Invasive and Non Invasive Breast Cancer. Review Journal of Neurological & Medical Sciences Review. https://doi.org/10.62019/kw5f4656
Vancouver
Jabeen S, Afshan R, Baig M, Ahtsham M, Ahmed S, Ali R, et al. A Narrative Review of Prevalence of Her2 Positive Invasive and Non Invasive Breast Cancer. Review Journal of Neurological & Medical Sciences Review. 2025. doi:10.62019/kw5f4656
BibTeX
@article{Jabeen2025,
author = {Jabeen, Sidra and Afshan, Roshan and Baig, Maryam and Ahtsham, Muhammad and Ahmed, Sadaf and Ali, Rimsha and Kashif, Ayesha and Zhaira*, Dua and Gulzar, Nadia and Raja, Zeeshan},
title = {A Narrative Review of Prevalence of Her2 Positive Invasive and Non Invasive Breast Cancer},
journal = {Review Journal of Neurological & Medical Sciences Review},
year = {2025},
doi = {10.62019/kw5f4656}
}
EUVIMED